Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125656021 | 12565602 | 1 | I | 20140920 | 20160701 | 20160718 | 20160718 | PER | US-CELGENEUS-USA-2016070224 | CELGENE | 55.63 | YR | Y | 0.00000 | 20160718 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125656021 | 12565602 | 1 | PS | THALOMID | THALIDOMIDE | 1 | Oral | 200 MILLIGRAM | U | 20785 | 200 | MG | CAPSULES | QD | |||||
| 125656021 | 12565602 | 2 | SS | VELCADE | BORTEZOMIB | 1 | Intravenous drip | U | 66188 | 1 | MG/M**2 | INJECTION | |||||||
| 125656021 | 12565602 | 3 | SS | CYTOXAN | CYCLOPHOSPHAMIDE | 1 | Intravenous drip | 1 MILLIGRAM/SQ. METER | U | 0 | 400 | MG/M**2 | INJECTION | ||||||
| 125656021 | 12565602 | 4 | SS | REVLIMID | LENALIDOMIDE | 1 | Oral | 400 MILLIGRAM/SQ. METER | U | 21880 | 25 | MG | CAPSULES | ||||||
| 125656021 | 12565602 | 5 | SS | ADRIAMYCIN | DOXORUBICIN HYDROCHLORIDE | 1 | Intravenous drip | U | 0 | 10 | MG/M**2 | INJECTION | |||||||
| 125656021 | 12565602 | 6 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Oral | U | 0 | 40 | MG/M**2 | UNKNOWN | |||||||
| 125656021 | 12565602 | 7 | SS | CISPLATIN. | CISPLATIN | 1 | Intravenous drip | U | 72883 | 10 | MG/M**2 | INJECTION | |||||||
| 125656021 | 12565602 | 8 | SS | ETOPOSIDE. | ETOPOSIDE | 1 | Intravenous drip | U | 72883 | 40 | MG/M**2 | INJECTION |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125656021 | 12565602 | 1 | Plasma cell myeloma |
| 125656021 | 12565602 | 2 | Plasma cell myeloma |
| 125656021 | 12565602 | 3 | Plasma cell myeloma |
| 125656021 | 12565602 | 4 | Plasma cell myeloma |
| 125656021 | 12565602 | 5 | Plasma cell myeloma |
| 125656021 | 12565602 | 6 | Plasma cell myeloma |
| 125656021 | 12565602 | 7 | Plasma cell myeloma |
| 125656021 | 12565602 | 8 | Plasma cell myeloma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125656021 | 12565602 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125656021 | 12565602 | Plasma cell myeloma |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125656021 | 12565602 | 1 | 20140812 | 20140823 | 0 | |
| 125656021 | 12565602 | 2 | 20140812 | 20140823 | 0 | |
| 125656021 | 12565602 | 3 | 20140812 | 20140823 | 0 | |
| 125656021 | 12565602 | 4 | 20140528 | 20140806 | 0 | |
| 125656021 | 12565602 | 5 | 20140812 | 20140823 | 0 | |
| 125656021 | 12565602 | 6 | 20140812 | 20140823 | 0 | |
| 125656021 | 12565602 | 7 | 20140812 | 20140823 | 0 | |
| 125656021 | 12565602 | 8 | 20140812 | 20140823 | 0 |